Report no.1 - Received from: US Consumer relations on 27-Aug-2012, Reference No: C240164650.
Suspect drug: Childrens Mucinex Cough Cherry
Dosing: One daily between 25-Aug-2012 to 27-Aug-2012
Case reference number RB-44202-2012 is a spontaneous case report sent by a consumer or other non health 
professional which refers to a female aged 9 years.
Patient had been exposed to Children Mucinex Cough Cherry(oral)for unknown indication. Patient's mother stated 
that her daughter aged 9 years has been developing nose bleeds and headaches after using children's mucinex. 
Print Time: 15-JUL-2016 02:45 PM If a field is blank, there is no data for that field Page 200 of 250
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
She has been
giving her daughter the recommended dose for the past 3 days and each time she has taken it, her nose begins to 
bleed and she develops a headache. She stated that she has given the medicine to her on 25-Aug-2012 to 27-Aug-
2012 at 2.30pm. No further information was available.
The reaction was deemed serious by the reporter because it was classed as other Medically significant due to nasal
bleeding.
The reporter's causality for the case is Possible. The reporting consumer or other non health professional's clinical 
assessment for drug CHILDREN MUCINEX COUGH CHERRY[Guaifenesin] is as follows: serious; with a 
relatedness of Possible. 
The company's assessment for the case was possible and unlisted.
Case outcome: Not Recovered / Not Resolved.
Reporter Assessment Narrative: The reporter's causality for the case is Possible. The reporting consumer or other 
non health professional's clinical assessment for drug CHILDREN MUCINEX COUGH CHERRY[Guaifenesin] is as 
follows: serious; with a relatedness of Possible.
01-MAR-2016 : Case downgrade from serious to non serious during ongoing benefit risk assessment,  cases was 
reviewed and re-evaluated by the internal  consumer safety review panel as non serious 01 03 2016